Search by Drug Name or NDC

NDC 72888-0118-05 CEVIMELINE HYDROCHLORIDE 30 mg/1 Details

CEVIMELINE HYDROCHLORIDE 30 mg/1

CEVIMELINE HYDROCHLORIDE is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Advagen Pharma Ltd. The primary component is CEVIMELINE HYDROCHLORIDE.

MedlinePlus Drug Summary

Cevimeline is used to treat the symptoms of dry mouth in patients with Sjogren's syndrome (a condition that affects the immune system and causes dryness of certain parts of the body such as the eyes and mouth). Cevimeline is in a class of medications called cholinergic agonists. It works by increasing the amount of saliva in the mouth.

Related Packages: 72888-0118-05
Last Updated: 05/26/2024
MedLinePlus Full Drug Details: Cevimeline

Product Information

NDC	72888-0118
Product ID	72888-118_fac9903a-6fb9-3fe7-e053-6394a90a1a72
Associated GPIs
GCN Sequence Number	044913
GCN Sequence Number Description	cevimeline HCl CAPSULE 30 MG ORAL
HIC3	J1A
HIC3 Description	PARASYMPATHETIC AGENTS
GCN	12624
HICL Sequence Number	021080
HICL Sequence Number Description	CEVIMELINE HCL
Brand/Generic	Generic
Proprietary Name	CEVIMELINE HYDROCHLORIDE
Proprietary Name Suffix	n/a
Non-Proprietary Name	CEVIMELINE HYDROCHLORIDE
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE
Route	ORAL
Active Ingredient Strength	30
Active Ingredient Units	mg/1
Substance Name	CEVIMELINE HYDROCHLORIDE
Labeler Name	Advagen Pharma Ltd
Pharmaceutical Class	Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA216682
Listing Certified Through	2024-12-31

Package

NDC 72888-0118-05 (72888011805)

Pricing Information	N/A
NDC Package Code	72888-118-05
Billing NDC	72888011805
Package	500 CAPSULE in 1 BOTTLE, PLASTIC (72888-118-05)
Marketing Start Date	2023-05-03
NDC Exclude Flag	N